J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 73 drugs in this drug class and its subclasses.
- 73 prescription (Rx)
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J05 Antivirals for systemic use 246 drugs
- J05A Direct acting antivirals 246 drugs
-
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
- J05AB01 Acyclovir 20 drugs
- J05AB06 Ganciclovir 6 drugs
- J05AB09 Famciclovir 10 drugs
- J05AB11 Valaciclovir 26 drugs
- J05AB12 Cidofovir 1 drug
- J05AB14 Valganciclovir 7 drugs
- J05AB16 Remdesivir 2 drugs
- J05AB17 Brincidofovir 1 drug
-
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
- J05A Direct acting antivirals 246 drugs
- J05 Antivirals for systemic use 246 drugs
Active ingredients of the class
- Acyclovir 14 drugs
- Acyclovir (acyclovir sodium) 6 drugs
- Brincidofovir 1 drug
- Cidofovir (cidofovir dihydrate) 1 drug
- Famciclovir 10 drugs
- Ganciclovir (ganciclovir sodium) 6 drugs
- Remdesivir 2 drugs
- Valacyclovir (valacyclovir hydrochloride) 24 drugs
- Valacyclovir (valacyclovir hydrochloride monohydrate) 2 drugs
- Valganciclovir (valganciclovir hydrochloride) 7 drugs
Drugs in the class and its subclasses
Other classes of the same level
- J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
- J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
- J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
- J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
- J05AP Antivirals for treatment of HCV infections 16 drugs
- J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
- J05AX Other antivirals 13 drugs
Other names of the drug class
- Czech: J05AB Nukleosidy a nukleotidy, kromě inhibitorů reverzní transkriptázy
- English (United Kingdom): J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- French: J05AB nucléosides et nucléotides, inhibiteurs de la transcriptase reverse exclus
- German: J05AB Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase
- Spanish: J05AB Nucleosidos/nucleotidos excluid.inhibid.transcripasa inversa
- German (Austria): J05AB Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase
- Italian: J05AB NUCLEOSIDI E NUCLEOTIDI, ESCLUSI GLI INIBITORI DELLA TRANSCRITTASI INVERSA
- Polish: J05AB Nukleozydy i nukleotydy, z wyjątkiem inhibitorów odwrotnej transkryptazy
- Turkish: J05AB Nükleozitler ve nükleotitler hariç. ters transkriptaz inhibitörleri
- Portuguese (Brazil): J05AB Nucleosídeos e Nucleotídeos com exclusão dos inibidores da transcriptase reversa
- Slovak: J05AB Nukleozidy a nukleotidy s výnimkou inhibítorov reverznej transkriptázy
- German (Switzerland): J05AB Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase
- French (Switzerland): J05AB Nucléosides et nucléotides, inhibiteurs de la transcriptase reverse exclus
- Italian (Switzerland): J05AB Nucleosidi e nucleotidi, esclusi gli inibitori della transcrittasi inversa
- Dutch: J05AB Nucleosiden en nucleotiden, excl. reverse-transcriptaseremmers
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J05AB
Ask your doctor or pharmacist for advice.